C and or its affiliates make a market in the stock of GW Pharmaceuticals Plc, Tilray, Turning Point Brands and Canopy Growth Corporation securities. Cowen and Company, LLC served as the placement agent in connection with Tilray's Series A preferred stock financing in February and March 2018. Cowen and Company, LLC mana

onths Buy (a) 473 64.01% 116 24.52% Hold (b) 259 35.05% 20 7.72% Sell (c) 7 0.95% 0 0.00% (a) Corresponds to “Outperform” rated stocks as defined in Cowen and Company, LLC's equity research rating definitions. (b) Corresponds to "Market Perform” as defined in Cowen and Company, LLC's equity research ratings definitions. (